Allogene Therapeutics (ALLO) Closes $200.4M Public Offering of Common Stock

May 2, 2026 - 13:00

Allogene Therapeutics (ALLO) Closes $200.4M Public Offering of Common Stock

Tags:

Previous Article

Target launches new kind of supply chain facility

Posco signs US$765m deal for 30% stake in Australian lithium mines

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

HSBC Holdings plc (HSBC): One of the Low Risk High Growth Stocks to Buy?

HSBC Holdings plc (HSBC): One of the Low Risk High Grow...

Apr 26, 2026

IBM stock tanks as quarterly results fail to quell AI concerns

IBM stock tanks as quarterly results fail to quell AI c...

Apr 23, 2026

Is Merck & Co. (MRK) One of the Best Bear Market Stocks to Invest in Right Now?

Is Merck & Co. (MRK) One of the Best Bear Market Stocks...

Apr 26, 2026